CSIRTS // UNIFIED SECURITY ADVISORY FEEDSYS ● ONLINE · POWERED BY INTELFUSIONS.COM

← Back to feed

CVE-2026-47017: Vulnerability in the PeopleSoft Enterprise PeopleTools product of Oracle PeopleSoft (component: Process Scheduler). Supported versions that are affected are 8.61 and 8.62. Easily

highCVSS 8.7CVE-2026-47017
Vulnerability in the PeopleSoft Enterprise PeopleTools product of Oracle PeopleSoft (component: Process Scheduler). Supported versions that are affected are 8.61 and 8.62. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise PeopleSoft Enterprise PeopleTools. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in PeopleSoft Enterprise PeopleTools, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all PeopleSoft Enterprise PeopleTools accessible data as well as unauthorized access to critical data or complete access to all PeopleSoft Enterprise PeopleTools accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

Details

Source
NVD Recent CVEs (US · database · site)
Severity
high — CVSS 8.7
Published
2026-07-21
Last updated
2026-07-27
Exploitation
Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-47017

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Referenced CVEs

CVECSIRTS overviewExternal
CVE-2026-47017coverage & exploitation statusNVD · CVE.org

Same CVEs, other sources

How other CERTs, PSIRTs and databases cover the vulnerabilities in this advisory.

Recent advisories for PeopleSoft Enterprise PeopleTools

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

More from NVD Recent CVEs